An association has been observed between a deregulated PGC1α expression, such as decreased PGC1α levels in breast, prostate, melanoma, and renal cell carcinoma (RCC), and a poor prognosis [9,12,13,14]. Here, PPARGC1A is linked to renal cell carcinoma.